Stockscreener 앱 받기
86.00
1.16%
0.99
전일 마감가:
$85.01
열려 있는:
$84.81
하루 거래량:
2.08M
Relative Volume:
1.74
시가총액:
$9.58B
수익:
$13.38B
순이익/손실:
$418.00M
주가수익비율:
25.97
EPS:
3.3112
순현금흐름:
$391.00M
1주 성능:
-0.44%
1개월 성능:
+1.12%
6개월 성능:
+9.95%
1년 성능:
+35.24%
1일 변동 폭
$0.00
$0.00
1주일 범위
$83.84
$87.36
52주 변동 폭
$62.15
$92.18
헨리 샤인 Stock (HSIC) Company Profile
명칭
Henry Schein Inc
전화
(631) 843-5500
주소
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
86.00 | 9.58B | 13.38B | 418.00M | 391.00M | 3.3112 |
MCK
Mckesson Corp
|
1,012.34 | 118.03B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
338.48 | 64.59B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
255.64 | 59.20B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
1.22 | 1.05B | 14.85M | -136.07M | 7.25M | -0.4726 |
헨리 샤인 Stock (HSIC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-07-09 | 개시 | BMO Capital Markets | Market Perform |
| 2026-06-11 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2026-04-16 | 개시 | BTIG Research | Neutral |
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-02-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-08-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-07-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | 개시 | Wells Fargo | Equal Weight |
| 2025-01-06 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-07-22 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-10 | 업그레이드 | Stifel | Hold → Buy |
| 2022-08-08 | 업그레이드 | UBS | Sell → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-01-31 | 개시 | Morgan Stanley | Underweight |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | 재개 | Credit Suisse | Neutral |
| 2021-02-08 | 재개 | Piper Sandler | Overweight |
| 2021-01-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | 개시 | Wolfe Research | Underperform |
| 2019-05-15 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-01-17 | 개시 | UBS | Sell |
| 2019-01-03 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2019-01-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | 재확인 | Barrington Research | Outperform |
| 2018-10-25 | 다운그레이드 | Edward Jones | Hold → Sell |
| 2018-10-19 | 재개 | Goldman | Neutral |
| 2018-10-04 | 재확인 | Robert W. Baird | Outperform |
| 2018-08-07 | 재확인 | Stifel | Hold |
| 2018-04-24 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-04-04 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
모두보기
헨리 샤인 주식(HSIC)의 최신 뉴스
Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET - Business Wire
Unpacking Q2 Earnings: Henry Schein (NASDAQ:HSIC) In The Context Of Other Dental Equipment & Technology Stocks - Yahoo Finance
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term - Zacks Investment Research
What You Need To Know Ahead of Henry Schein's Earnings Release - Barchart.com
What You Need To Know Ahead of Henry Schein's Earnings Release - inkl
Henry Schein Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Henry Schein Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Baird Adjusts Henry Schein Price Target to $107 From $109 - marketscreener.com
Baird Adjusts Henry Schein Price Target to $107 From $109 - Yahoo Finance
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Leerink Partners Adjusts Price Target on Henry Schein to $92 From $96 - www.marketscreener.com
Leerink Partners Adjusts Price Target on Henry Schein to $92 From $96 - Yahoo Finance
Henry Schein, Inc. Stock 12‑Month Price Target Cut to $97.27, Implies 16% Upside - TradingView
Henry Schein appoints Emmanuel Caprais as CFO - MedTech Dive
Henry Schein marks 20 years of Practice Pink - DrBicuspid.com
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Why is Henry Schein stock sliding today? - Investing.com
Henry Schein, Inc. Announces CFO Changes, Effective November 4, 2026 - marketscreener.com
Henry Schein names Emmanuel Caprais CFO: what it means for Henry Schein stock - AD HOC NEWS
Henry Schein (HSIC) Announces CFO Transition: Emmanuel Caprais t - GuruFocus
Henry Schein names new CFO - HME News
Henry Schein names Emmanuel Caprais as new CFO - Investing.com
Henry Schein Appoints Emmanuel Caprais as CFO Effective November 2026 - Kalkine Media
Henry Schein names former ITT executive as new CFO - StreetInsider
Henry Schein Announces Chief Financial Officer Leadership Transition - Business Wire
Henry Schein stock fell 1.39 percent as analysts set USD 110 target - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Henry Schein, Inc. (HSIC) Options Chain - Yahoo! Finance Canada
HSIC or MMSI: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Henry Schein Celebrates 20 Years of Practice Pink - Dentistry Today
Should Value Investors Buy Henry Schein (HSIC) Stock? - Zacks Investment Research
Should Value Investors Buy Henry Schein (HSIC) Stock? - Yahoo Finance
Henry Schein Marks 20th Anniversary of Practice Pink Initiative - Orthodontic Products
Henry Schein expands credit line while analysts rate Henry Schein stock Moderate Buy - AD HOC NEWS
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein Cares Celebrates 25 Years of Corporate Citizenship - Dentistry Today
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein Cares Marks 25 Years of Helping Health Happen® - Eagle-Tribune
Henry Schein Cares Marks 25 Years of Helping Health Happen® - Business Wire
Henry Schein Cares Marks 25 Years of Helping Health Happen® - Yahoo Finance
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Henry Schein (HSIC): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Henry Schein stock reflects raised 2026 guidance at USD 86.37 - AD HOC NEWS
Ex-Henry Schein manager gets jail for major embezzlement - DrBicuspid.com
Henry Schein Inc Lobbying Profile, 2011 - OpenSecrets
Henry Schein credit supervisor sentenced to prison for embezzling $1.6M from Melville company - Newsday
Henry Schein Q2FY26 Results: Non-GAAP EPS up 15.5%, guidance raised - scanx.trade
Transcript: Henry Schein Q2 2026 Earnings Conference Call - Benzinga
Is Henry Schein Stock Outperforming the Dow? - finance.yahoo.com
Is Henry Schein Stock Outperforming the Dow? - inkl
헨리 샤인 (HSIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
헨리 샤인 주식 (HSIC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| HERRING JOSEPH L | Former Director |
Jun 30 '26 |
Proposed Sale |
84.29 |
28,791 |
2,426,793 |
0 |
| Stanley M. Bergman | Affiliate |
Jun 16 '26 |
Proposed Sale |
81.09 |
16,933 |
1,373,097 |
0 |
| DANIEL WILLIAM K | Director |
May 11 '26 |
Buy |
69.19 |
10,000 |
691,900 |
20,000 |
| Popeck Thomas C | CEO, Henry Schein Products |
Mar 19 '26 |
Sale |
72.79 |
1,355 |
98,630 |
86,182 |
| Popeck Thomas C | Officer |
Mar 19 '26 |
Proposed Sale |
72.79 |
1,355 |
98,630 |
0 |
| KUEHN KURT P | Director |
Mar 10 '26 |
Proposed Sale |
78.96 |
2,844 |
224,565 |
0 |
| KUEHN KURT P | Director |
Mar 10 '26 |
Sale |
78.96 |
2,844 |
224,565 |
15,420 |
| LASKAWY PHILIP A | Director |
Mar 05 '26 |
Proposed Sale |
80.36 |
2,844 |
228,544 |
0 |
| LASKAWY PHILIP A | Director |
Mar 05 '26 |
Sale |
80.36 |
2,844 |
228,544 |
21,961 |
| MLOTEK MARK E | Officer |
Mar 04 '26 |
Proposed Sale |
80.80 |
5,925 |
478,739 |
0 |
3.94%
자본화:
|
볼륨(24시간):